Elcelyx Therapeutics Secures $4,000,000 Series B Funding Round

  • Feed Type
  • Date
    8/13/2012
  • Company Name
    Elcelyx Therapeutics
  • Mailing Address
    11995 El Camino Real San Diego, CA 92130
  • Company Description
    Elcelyx Therapeutics of San Diego is a stealth mode diabetes related biotechnology company.
  • Website
    http://www.elcelyx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    The new financing will support clinical trials for proprietary product candidates Lovidia(TM) for use in nutritional supplement, food and beverage applications, and NewMet(TM) for patients with Type 2 diabetes.
  • M&A Terms
  • Venture Investor
    Morgenthaler Ventures
  • Venture Investor
    Kleiner Perkins Caufield & Byers
  • Venture Investor
    Technology Partners

By posting a comment, you agree to our terms and conditions.